Enteric involvement in hospitalised patients with COVID-19 outside Wuhan.
作者信息
Wan Yunle, Li Jie, Shen Lihan, Zou Yifeng, Hou Linlin, Zhu Lixin, Faden Howard S, Tang Zhipeng, Shi Mang, Jiao Na, Li Yichen, Cheng Sijing, Huang Yibo, Wu Dingfeng, Xu Zhifeng, Pan Linnuo, Zhu Jun, Yan Guangjun, Zhu Ruixin, Lan Ping
机构信息
Department of Hepato-Biliary Surgery, Sixth Affiliated Hosptial, Sun Yat-sen University, Guangzhou, China.
Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, China.
出版信息
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):534-535. doi: 10.1016/S2468-1253(20)30118-7. Epub 2020 Apr 15.
Abstract
摘要
相似文献
1
Enteric involvement in hospitalised patients with COVID-19 outside Wuhan.武汉以外地区新冠肺炎住院患者的肠道受累情况。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):534-535. doi: 10.1016/S2468-1253(20)30118-7. Epub 2020 Apr 15.
2
Effect of Gastrointestinal Symptoms in Patients With COVID-19.新型冠状病毒肺炎患者胃肠道症状的影响
Gastroenterology. 2020 Jun;158(8):2294-2297. doi: 10.1053/j.gastro.2020.03.020. Epub 2020 Mar 19.
3
High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California.严重急性呼吸综合征冠状病毒2型患者并发胃肠道表现的高患病率：来自加利福尼亚州的早期经验
Gastroenterology. 2020 Aug;159(2):775-777. doi: 10.1053/j.gastro.2020.04.008. Epub 2020 Apr 10.
4
The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.新型冠状病毒病患者的肝损伤和胃肠道症状：系统评价和荟萃分析。
Clin Res Hepatol Gastroenterol. 2020 Oct;44(5):653-661. doi: 10.1016/j.clinre.2020.04.012. Epub 2020 May 12.
5
Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study From the United States.胃肠道症状与2019冠状病毒病：一项来自美国的病例对照研究。
Gastroenterology. 2020 Jul;159(1):373-375.e2. doi: 10.1053/j.gastro.2020.04.017. Epub 2020 Apr 12.
6
Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children.新型冠状病毒肺炎患儿的胃肠道特征：8例患儿不同表现的观察
Lancet Child Adolesc Health. 2020 Jul;4(7):e19-e20. doi: 10.1016/S2352-4642(20)30165-6. Epub 2020 May 20.
7
Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study.美国严重急性呼吸综合征冠状病毒2感染患者胃肠道症状的患病率及特征：一项多中心队列研究
Gastroenterology. 2020 Aug;159(2):765-767.e2. doi: 10.1053/j.gastro.2020.04.045. Epub 2020 Apr 22.
8
Diarrhea Is Associated With Prolonged Symptoms and Viral Carriage in Corona Virus Disease 2019.腹泻与 2019 冠状病毒病患者症状迁延和病毒携带有关。
Clin Gastroenterol Hepatol. 2020 Jul;18(8):1753-1759.e2. doi: 10.1016/j.cgh.2020.04.030. Epub 2020 Apr 18.
9
Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications.纽约大量新冠病毒感染患者的2019冠状病毒病的胃肠道和肝脏表现：临床意义
Gastroenterology. 2020 Sep;159(3):1137-1140.e2. doi: 10.1053/j.gastro.2020.05.010. Epub 2020 May 8.
10
Can COVID-19 present unusual GI symptoms?新型冠状病毒肺炎会出现不寻常的胃肠道症状吗？
J Microbiol Immunol Infect. 2020 Jun;53(3):384-385. doi: 10.1016/j.jmii.2020.03.020. Epub 2020 Mar 21.
引用本文的文献
1
COVID-19 and Upper Gastrointestinal Bleeding; Etiology, Risk Factors, and Outcomes: A Case-Control Study.新型冠状病毒肺炎与上消化道出血：病因、危险因素及结局的病例对照研究
Middle East J Dig Dis. 2025 Jan;17(1):25-30. doi: 10.34172/mejdd.2025.406. Epub 2025 Jan 31.
2
Preferential apical infection of Caco-2 intestinal cell monolayers by SARS-CoV-2 is associated with damage to cellular barrier integrity: Implications for the pathophysiology of COVID-19.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）对Caco-2肠细胞单层的优先顶端感染与细胞屏障完整性受损有关：对2019冠状病毒病病理生理学的启示。
PLoS One. 2025 Feb 10;20(2):e0313068. doi: 10.1371/journal.pone.0313068. eCollection 2025.
3
Rates, Risk Factors, and Outcomes of Nonvariceal Upper Gastrointestinal Bleeding in Patients Hospitalized for COVID-19 in the United States.美国因新冠肺炎住院患者非静脉曲张性上消化道出血的发生率、危险因素及结局
Curr Med Sci. 2024 Dec;44(6):1202-1209. doi: 10.1007/s11596-024-2838-6. Epub 2024 Dec 14.
4
Impact of preexisting digestive problems on the gastrointestinal symptoms of patients with omicron variant of SARS-CoV-2 infection.奥密克戎变异株 SARS-CoV-2 感染患者的消化道症状与原有消化道问题的关系。
PLoS One. 2024 Oct 30;19(10):e0312545. doi: 10.1371/journal.pone.0312545. eCollection 2024.
5
Gut microbiota: a potential influencer of insomnia occurring after COVID-19 infection.肠道微生物群：新冠病毒感染后失眠的潜在影响因素
Front Psychiatry. 2024 Jul 23;15:1423715. doi: 10.3389/fpsyt.2024.1423715. eCollection 2024.
6
ACE2 mediates tryptophan alleviation on diarrhea by repairing intestine barrier involved mTOR pathway.ACE2 通过修复涉及 mTOR 途径的肠屏障来介导色氨酸缓解腹泻。
Cell Mol Biol Lett. 2024 Jun 14;29(1):90. doi: 10.1186/s11658-024-00603-8.
7
Relationship between gastrointestinal symptoms and COVID-19 infection in the pediatric population: a scoping review.儿童人群中胃肠道症状与 COVID-19 感染的关系：范围综述。
Rev Esc Enferm USP. 2024 May 6;58:e20230365. doi: 10.1590/1980-220X-REEUSP-2023-0365en. eCollection 2024.
8
SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9.SARS-CoV-2 刺突蛋白通过 CEACAM5 和半乳糖凝集素-9 的相互作用诱导肠道屏障功能障碍。
Front Immunol. 2024 Apr 15;15:1303356. doi: 10.3389/fimmu.2024.1303356. eCollection 2024.
9
Development and management of gastrointestinal symptoms in long-term COVID-19.长期新冠患者胃肠道症状的发展与管理
Front Microbiol. 2023 Dec 14;14:1278479. doi: 10.3389/fmicb.2023.1278479. eCollection 2023.
10
The Prevalence of Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎患者胃肠道出血的发生率：系统评价和荟萃分析。
Medicina (Kaunas). 2023 Aug 21;59(8):1500. doi: 10.3390/medicina59081500.
本文引用的文献
1
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.中国湖北有消化道症状的 COVID-19 患者的临床特征：一项描述性、横断面、多中心研究。
Am J Gastroenterol. 2020 May;115(5):766-773. doi: 10.14309/ajg.0000000000000620.
2
Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19).不要忽视2019新型冠状病毒病（COVID-19）患者的消化症状。
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1636-1637. doi: 10.1016/j.cgh.2020.03.043. Epub 2020 Mar 20.
3
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
4
Evidence for Gastrointestinal Infection of SARS-CoV-2.新型冠状病毒2019（SARS-CoV-2）胃肠道感染的证据。
Gastroenterology. 2020 May;158(6):1831-1833.e3. doi: 10.1053/j.gastro.2020.02.055. Epub 2020 Mar 3.
5
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.2019-nCoV 感染患者的分子和血清学调查：多种脱落途径的意义。
Emerg Microbes Infect. 2020 Feb 17;9(1):386-389. doi: 10.1080/22221751.2020.1729071. eCollection 2020.
6
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
7
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
8
First Case of 2019 Novel Coronavirus in the United States.美国首例 2019 新型冠状病毒病例。
N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection.严重急性呼吸综合征相关冠状病毒感染的肠道受累情况。
Gastroenterology. 2003 Oct;125(4):1011-7. doi: 10.1016/s0016-5085(03)01215-0.
Zotero 插件